HEART FAILURE REVIEWS

Scope & Guideline

Connecting Researchers and Clinicians in Cardiac Medicine

Introduction

Immerse yourself in the scholarly insights of HEART FAILURE REVIEWS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1382-4147
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1996 to 2024
AbbreviationHEART FAIL REV / Heart Fail. Rev.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal "Heart Failure Reviews" aims to provide comprehensive insights into various aspects of heart failure, focusing on advancements in treatment, diagnosis, and management strategies. It encompasses a wide range of topics, including clinical studies, systematic reviews, and innovative therapies, making significant contributions to the field of cardiology.
  1. Clinical Management of Heart Failure:
    The journal emphasizes the importance of clinical management strategies for heart failure, including pharmacological treatments, lifestyle interventions, and the use of advanced therapies such as device management and surgical options.
  2. Innovative Therapeutic Approaches:
    Research published in the journal often explores novel therapeutic approaches, such as the use of SGLT2 inhibitors, GLP-1 receptor agonists, and other emerging drugs, highlighting their efficacy and mechanisms in heart failure management.
  3. Diagnosis and Prognosis:
    The journal focuses on advancements in diagnostic techniques, including echocardiography, cardiac MRI, and biomarkers, as well as prognostic tools that aid in assessing heart failure severity and outcomes.
  4. Pathophysiology and Mechanisms:
    A significant portion of the articles delve into the underlying mechanisms and pathophysiology of heart failure, including molecular, genetic, and inflammatory aspects that contribute to disease progression.
  5. Comorbidities and Multidisciplinary Care:
    The journal promotes the understanding of comorbid conditions associated with heart failure, advocating for a multidisciplinary approach to patient care that addresses both cardiac and non-cardiac issues.
The journal has shown an evolving focus on emerging trends and novel therapeutic approaches in heart failure management. Recent publications reflect a growing interest in integrating technology, personalized medicine, and innovative pharmacotherapies.
  1. Digital Health and Telemonitoring:
    The integration of digital health technologies and telemonitoring for heart failure management is increasingly highlighted, showcasing the potential for improving patient outcomes through remote monitoring and engagement.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF is gaining traction, with a focus on its unique challenges, therapeutic options, and the development of specific management guidelines, reflecting a better understanding of this complex condition.
  3. Personalized and Precision Medicine:
    There is a growing trend towards personalized medicine in heart failure treatment, with an emphasis on tailoring therapies based on genetic, molecular, and phenotypic characteristics of patients.
  4. Innovative Biomarkers and Diagnostic Tools:
    The exploration of novel biomarkers and advanced diagnostic tools, such as cardiac imaging techniques and machine learning algorithms, is becoming more prevalent, enhancing the ability to stratify risk and personalize treatment.
  5. Impact of Lifestyle Modifications:
    Recent publications increasingly emphasize the significance of lifestyle modifications, including dietary and exercise interventions, as integral components of heart failure management.

Declining or Waning

While the journal continues to thrive in many areas, certain themes appear to be losing prominence in recent publications. This may reflect shifts in research focus or advancements in treatment options that have rendered some topics less critical or outdated.
  1. Traditional Pharmacological Approaches:
    There seems to be a decreasing emphasis on traditional pharmacological treatments such as ACE inhibitors and beta-blockers, as newer therapies like SGLT2 inhibitors gain prominence in heart failure management.
  2. Isolated Studies on Specific Comorbidities:
    Research focusing solely on specific comorbidities without integrating them into a broader heart failure management context is becoming less frequent, indicating a shift towards more holistic approaches.
  3. Generalized Risk Factors:
    Articles that discuss generalized risk factors for heart failure without specific context or innovative approaches are appearing less often, as the field moves towards more targeted and individualized treatment strategies.

Similar Journals

ESC Heart Failure

Bridging gaps in heart failure research and clinical application.
Publisher: WILEY PERIODICALS, INCISSN: 2055-5822Frequency: 6 issues/year

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

HEART AND VESSELS

Exploring Innovations in Cardiology and Vascular Medicine
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Cardiac Failure Review

Fostering discussions that shape cardiac care.
Publisher: RADCLIFFE CARDIOLOGYISSN: 2057-7540Frequency: 1 issue/year

Cardiac Failure Review, published by Radcliffe Cardiology, is a leading open-access journal dedicated to advancing the understanding and management of cardiac failure. With an ISSN of 2057-7540 and an E-ISSN of 2057-7559, this journal has gained significant recognition in the field, achieving a Q1 ranking in Cardiology and Cardiovascular Medicine as of 2023. Its impressive positioning at rank #97 out of 387 in Scopus further highlights its impact, placing it within the top 25th percentile of its category. Since transitioning to open access in 2019, Cardiac Failure Review has become increasingly accessible, ensuring that critical research findings are available to a global audience. The journal's focus spans innovative treatments, emerging technologies, and comprehensive reviews, effectively meeting the needs of researchers, clinicians, and students alike. With a commitment to excellence in cardiovascular medicine, Cardiac Failure Review plays a vital role in disseminating knowledge and fostering discussions that drive the field forward.

PROGRESS IN PEDIATRIC CARDIOLOGY

Innovating Research in Pediatric Cardiology
Publisher: ELSEVIER IRELAND LTDISSN: 1058-9813Frequency: 4 issues/year

PROGRESS IN PEDIATRIC CARDIOLOGY is a notable journal dedicated to advancing research and knowledge in the fields of pediatric cardiology and cardiovascular health in children. Published by Elsevier Ireland Ltd, this journal serves as a vital resource for clinicians, researchers, and healthcare professionals who engage with the complexities of heart diseases affecting pediatric populations. With ISSN 1058-9813 for print and 1558-1519 for online issues, it operates from Ireland and reflects a commitment to disseminating high-quality, peer-reviewed research since its inception in 1992. The journal is ranked in the Q3 category in both cardiology and pediatrics, indicating its relevance in the academic community, despite recent performance metrics showing room for growth within the competitive landscape. Researchers and practitioners can expect to find cutting-edge findings and clinical studies that aim to improve outcomes in pediatric cardiology. While it does not offer Open Access, the breadth of research covers various critical aspects, contributing significantly to the field's ongoing development.

TEXAS HEART INSTITUTE JOURNAL

Transforming Cardiology Through Groundbreaking Studies.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Cardiology Research and Practice

Pioneering discoveries in cardiovascular medicine.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Exploring the Frontiers of Echocardiography
Publisher: WILEYISSN: 0742-2822Frequency: 12 issues/year

ECHOCARDIOGRAPHY: A Journal of Cardiovascular Ultrasound and Allied Techniques is a premier scholarly publication committed to advancing the field of cardiovascular imaging through the dissemination of high-quality research and clinical studies. Published by Wiley, this journal has been a vital resource since its inception in 1984, aiming to bridge the gap between ultrasound techniques and clinical practice over its converged years extending to 2024. With an ISSN of 0742-2822 and an E-ISSN of 1540-8175, the journal is indexed in notable databases and holds a respectable standing in its field, reflected in its Q3 rankings in Cardiovascular Medicine, Miscellaneous Medicine, and Radiology for 2023. Though currently not open access, the journal strives to provide valuable insights and innovative techniques to researchers, professionals, and students alike, fostering a deeper understanding of echocardiography and its impact on patient care. Located in the United States, the journal continues to serve as a cornerstone for contemporary cardiovascular research and education, ensuring that the latest advancements and practices are readily accessible to the medical community.

Kardiologia Polska

Exploring the Frontiers of Cardiovascular Medicine
Publisher: POLISH CARDIAC SOCISSN: 0022-9032Frequency: 12 issues/year

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

Journal of Cardiovascular Medicine

Empowering Clinicians with Cutting-Edge Cardiovascular Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Arquivos Brasileiros de Cardiologia

Exploring the frontiers of cardiovascular science since 1950.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.